Over the past decade, methamphetamine use has grown more popular in Myanmar, Thailand and Southern China. Based on in-depth interviews conducted with individuals who use methamphetamine, this briefing sheds light on the importance of promoting an environment that reinforces, rather than undermines, the ability of people who use methamphetamine to regulate their drug use, preserve their health and adopt safer practices.

Learn how lessening the barriers for small farmers while raising them for large companies can help to steer legal cannabis markets in a more sustainable and equitable direction based on principles of community empowerment, social justice, fair(er) trade and sustainable development.

Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.

Download the publication (PDF)

Neuropathic pain affects between 5% and 10% of the US population and can be refractory to treatment. Opioids may be recommended as a second-line pharmacotherapy but have risks including overdose and death. Cannabis has been shown to be effective for treating nerve pain without the risk of fatal poisoning. The author suggests that physicians who treat neuropathic pain with opioids should evaluate their patients for a trial of cannabis and prescribe it when appropriate prior to using opioids. This harm reduction strategy may reduce the morbidity and mortality rates associated with prescription pain medications.

Policy changes over the past five years or so have dramatically reshaped the global cannabis market. Not only has there been an unprecedented boom in medical markets, but following policy shifts in several jurisdictions a growing number of countries are also preparing for legal regulation of non-medical use. Such moves look set to bring a clear range of benefits in terms of health and human rights. As this groundbreaking Report, highlights, however, there are also serious concerns about the unfolding market dynamics.

In January 2019 the World Health Organization issued a collection of formal recommendations to reschedule cannabis and cannabis-related substances. These present an opportunity for African governments and civil society to further decolonise drug control approaches on the continent, as well as to strengthen the international legal basis for emerging medicinal cannabis programmes in several African countries.

Los cambios políticos ocurridos en los últimos cinco años han reconfigurado dramáticamente el mercado del cannabis. No solo ha habido un boom sin precedentes en el mercado medicinal sino que, siguiendo los cambios políticos en muchas jurisdicciones, un número creciente de países también se están preparando para la regulación legal del uso no medicinal. Tales movimientos son impulsados por el reconocimiento de la inefectividad probada de las políticas represivas durante décadas, que han acarreado graves consecuencias negativas y apuntan a proporcionar un amplio rango de beneficios en términos de la salud y los derechos humanos. Sin embargo, también hay serias preocupaciones acerca del despliegue de las dinámicas de mercado.

In July 2016, the Colombian government enacted Law 1787, which regulates the use of medicinal cannabis and its trade in the country. With this decision and a series of subsequent resolutions, Colombia joined the more than a dozen countries that have put into practice different types of regulation to explore the advantages of this plant as an alternative pharmaceutical.

Produced as part of a the "New Approaches in Harm Reduction Policies and Practices" project, this Country Report seeks to understand the drivers of Spanish cannabis policy today, and the possibilities for its future.

In order to better understand the situation around, and possibilities for, local and regional cannabis regulation, a series of six country reports were developed. The country reports provide detailed information about the state of cannabis policy, and the possibilities for change, within each country. This Report summarises some of the key findings from the research and explores opportunities, obstacles, and strategies for cannabis regulation at the municipal and regional level.

An official policy of giving a low law enforcement priority to small-scale possession or production of cannabis for personal use led to the emergence of Cannabis Social Clubs around Belgium. However, the attitude to cannabis can vary widely at the local level, and the future of these organised user groups is unclear. Produced as part of a the "New Approaches in Harm Reduction Policies and Practices" project, this Country Report seeks to understand the drivers of Belgian cannabis policy today, and the possibilities for its future.

In the 1990s Switzerland was one of the leaders of a movement towards harm reduction for heroin users. Today, the country is also re-thinking its cannabis policy, with municipalities pushing for experiments in more progressive models of regulation, and citizens pushing for legislative reform. Produced as part of a the "New Approaches in Harm Reduction Policies and Practices" project, this Country Report seeks to understand the drivers of Swiss cannabis policy today, and the possibilities for its future.

Is the aim of reducing cannabis cultivation realistic or beneficial for Morocco? What would it actually mean for the major production area the Rif – one of the poorest, most densely populated and environmentally fragile regions in the country? This briefing will give some historical background, discuss developments in the cannabis market, and highlight environmental and social consequences as well as the recent debate about regulation in Morocco and European policies.